Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

por Serin, D, Verrill, M, Jones, A, Delozier, T, Coleman, R, Kreuser, E-D, Mross, K, Longerey, B, Brandely, M
Publicado 2005